| Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 6700 | 2019 |
| The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ... Nature medicine 28 (3), 568-574, 2022 | 699 | 2022 |
| Semaglutide in patients with heart failure with preserved ejection fraction and obesity MN Kosiborod, SZ Abildstrøm, BA Borlaug, J Butler, S Rasmussen, ... New England Journal of Medicine 389 (12), 1069-1084, 2023 | 626 | 2023 |
| Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ... Jama 323 (14), 1353-1368, 2020 | 530 | 2020 |
| Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre … A Jorsal, C Kistorp, P Holmager, RS Tougaard, R Nielsen, A Hänselmann, ... European journal of heart failure 19 (1), 69-77, 2017 | 471 | 2017 |
| Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality EL Fosbøl, JH Butt, L Østergaard, C Andersson, C Selmer, K Kragholm, ... Jama 324 (2), 168-177, 2020 | 448 | 2020 |
| A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left … JJV McMurray, DL DeMets, SE Inzucchi, L Køber, MN Kosiborod, ... European journal of heart failure 21 (5), 665-675, 2019 | 372 | 2019 |
| Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF PS Jhund, SD Solomon, KF Docherty, HJL Heerspink, IS Anand, M Böhm, ... Circulation 143 (4), 298-309, 2021 | 288 | 2021 |
| Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction D Modin, B Claggett, C Sindet-Pedersen, MCH Lassen, KG Skaarup, ... Circulation 142 (21), 2080-2082, 2020 | 264 | 2020 |
| Incidence of cancer in patients with chronic heart failure: a long‐term follow‐up study A Banke, M Schou, L Videbaek, JE Møller, C Torp‐Pedersen, ... European journal of heart failure 18 (3), 260-266, 2016 | 232 | 2016 |
| N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis LH Madsen, S Ladefoged, P Corell, M Schou, PR Hildebrandt, D Atar Kidney international 71 (6), 548-554, 2007 | 218 | 2007 |
| Angiotensin receptor–neprilysin inhibition in acute myocardial infarction MA Pfeffer, B Claggett, EF Lewis, CB Granger, L Køber, AP Maggioni, ... New England Journal of Medicine 385 (20), 1845-1855, 2021 | 208 | 2021 |
| Effects of dapagliflozin in DAPA-HF according to background heart failure therapy KF Docherty, PS Jhund, SE Inzucchi, L Køber, MN Kosiborod, FA Martinez, ... European heart journal 41 (25), 2379-2392, 2020 | 202 | 2020 |
| Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique A Gabrielsen, R Videbaek, M Schou, M Damgaard, J Kastrup, P Norsk Clinical science 102 (2), 247-252, 2002 | 195 | 2002 |
| Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study JJ Rasmussen, C Selmer, PB Østergren, KB Pedersen, M Schou, ... PloS one 11 (8), e0161208, 2016 | 180 | 2016 |
| Semaglutide in patients with obesity-related heart failure and type 2 diabetes MN Kosiborod, MC Petrie, BA Borlaug, J Butler, MJ Davies, GK Hovingh, ... New England Journal of Medicine 390 (15), 1394-1407, 2024 | 178 | 2024 |
| Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19)—a Danish nationwide, register-based study K Kragholm, MP Andersen, TA Gerds, JH Butt, L Østergaard, ... Clinical Infectious Diseases 73 (11), e4025-e4030, 2021 | 162 | 2021 |
| Associations of empagliflozin with left ventricular volumes, mass, and function in patients with heart failure and reduced ejection fraction: a substudy of the empire HF … M Omar, J Jensen, M Ali, PH Frederiksen, C Kistorp, L Videbæk, ... JAMA cardiology 6 (7), 836-840, 2021 | 139 | 2021 |
| The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: a randomized, controlled clinical trial I Bressendorff, D Hansen, M Schou, A Pasch, L Brandi Clinical Journal of the American Society of Nephrology 13 (9), 1373-1380, 2018 | 134 | 2018 |
| The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study M D’Souza, D Nielsen, IM Svane, K Iversen, PV Rasmussen, C Madelaire, ... European heart journal 42 (16), 1621-1631, 2021 | 132 | 2021 |
